Skip to main content
. 2007 Dec;14(6):238–245. doi: 10.3747/co.2007.158

TABLE I.

New paradigms for vaccine efficacy as compared with those for conventional therapeutics

Efficacy of vaccines can be enhanced by biologic adjuvants
Tumour cell phenotype can be altered to enhance vaccine efficacy
Vaccines induce a dynamic process (important in combination scheduling)
As compared with tumour response (recist), patient response(survival) may be the more important criterion for efficacy

recist = Response Evaluation Criteria in Solid Tumors.